3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Recurrence
1
Peritoneal Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neoplasms, Glandular and Epithelial
1
Neoplasms
1
Immunologic Deficiency Syndromes
1
Glioblastoma
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Epstein-Barr Virus Infections
1
Cytomegalovirus Infections
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma in Situ
1
Adenoviridae Infections
1
Abdominal Neoplasms
1
Interventions
Temozolomide
12
Vincristine
9
Irinotecan
8
Cyclophosphamide
8
cabozantinib
6
X-Rays
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Etoposide
5
regorafenib
4
fludarabine
4
Radiotherapy
4
Phantoms, Imaging
4
Ifosfamide
4
Doxorubicin
4
Radiation
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
liposomal doxorubicin
2
ivosidenib
2
irinotecan sucrosofate
2
etoposide phosphate
2
abemaciclib
2
Zoledronic Acid
2
Topotecan
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Cell Count
×
1 year
×
Clear all
No trials found.